Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating eluxadoline for irritable bowel syndrome with diarrhea in patients with inadequate relief from prior loperamide; study completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eluxadoline (Viberzi) (eluxadoline)

Snippet

Sponsor: Allergan | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 4 | Status: COMPLETED | Results posted: 2019-02-15